Ulcerative Proctitis

Common Name(s)

Ulcerative Proctitis

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ulcerative Proctitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Ulcerative Proctitis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Ulcerative Proctitis" returned 22 free, full-text research articles on human participants. First 3 results:

Oral 5-Aminosalicylate, Mesalamine Suppository, and Mesalamine Enema as Initial Therapy for Ulcerative Proctitis in Clinical Practice with Quality of Care Implications.
 

Author(s): James M Richter, Nabeela K Arshi, Gerry Oster

Journal: Can J Gastroenterol Hepatol. 2016 ;2016():6928710.

 

Background. Ulcerative proctitis (UP) is typically treated initially with oral 5-aminosalicylate ("5-ASA"), mesalamine suppository, or mesalamine enema ("UP Rx"). Little is known about their effectiveness in practice. Methods. Using a US health insurance database, we identified new-onset ...

Last Updated: 22 Jul 2016

Go To URL
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
 

Author(s): David T Rubin, William J Sandborn, Brian Bosworth, Salam Zakko, Glenn L Gordon, Mark E Sale, Robert L Rolleri, Pamela L Golden, Andrew C Barrett, Enoch Bortey, William P Forbes

Journal: Dig. Dis. Sci.. 2015 Nov;60(11):3408-17.

 

Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis.

Last Updated: 27 Oct 2015

Go To URL
Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis.
 

Author(s): William J Sandborn, Brian Bosworth, Salam Zakko, Glenn L Gordon, David R Clemmons, Pamela L Golden, Robert L Rolleri, Jing Yu, Andrew C Barrett, Enoch Bortey, Craig Paterson, William P Forbes

Journal: Gastroenterology. 2015 Apr;148(4):740-750.e2.

 

Budesonide is a high-potency, second-generation corticosteroid designed to minimize systemic adverse consequences of conventional corticosteroids. We performed 2 randomized, phase 3 trials to evaluate the ability of budesonide rectal foam, formulated to optimize retention and provide ...

Last Updated: 25 Mar 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Ulcerative Proctitis" returned 2 free, full-text review articles on human participants. First 3 results:

Should maintenance therapy be performed in ulcerative proctitis? How long should it be continued?
 

Author(s): Oya Yönal, Gülen Hatemi, Sabahattin Kaymakoğlu

Journal: Turk J Gastroenterol. 2012 ;23 Suppl 2():21-4.

 

Last Updated: 11 Apr 2013

Go To URL
[Active and refractory ulcerative proctitis: an update].
 

Author(s): Gino Caselli M, George Pinedo M, Alvaro Zúñiga D, Manuel Alvarez L

Journal: Rev Med Chil. 2010 Jan;138(1):109-16.

 

Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology that affects a variable length of the colon, starting from the rectum. When the disease is confined to the rectum is called ulcerative proctitis (UP). Several studies have unsuccessfully attempted to determine ...

Last Updated: 2 Apr 2010

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)
 

Status: Recruiting

Condition Summary: Active Ulcerative Proctitis

 

Last Updated: 21 Oct 2016

Go to URL
Phenomics in Autoimmune and Inflammatory Diseases
 

Status: Recruiting

Condition Summary: Healthy Volunteer; Rheumatoid Arthritis; Ankylosing Spondylitis; Systemic Lupus Erythematosus/Antiphospholipid Syndrome; FMF; Cryopyrin-Associated Periodic Syndromes /TNF-receptor Associated Periodic Syndrome; Vasculitis; Uveitis; Myositis; Crohn's Disease; Ulcerative Rectocolitis; Type 1 Diabetes; Unclassified IAD Knee and/or Hip Arthritis, Muscular Dystrophy

 

Last Updated: 12 Dec 2016

Go to URL